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How cells determine when to initiate DNA replication is poorly understood. Here we report that in Saccha-
romyces cerevisiae overexpression of the dosage-dependent cell cycle regulator genes DCR2 (YLR361C) and
GID8 (DCR1/YMR135C) accelerates initiation of DNA replication. Cells lacking both GID8 and DCR2 delay
initiation of DNA replication. Genetic analysis suggests that Gid8p functions upstream of Dcr2p to promote
cell cycle progression. DCR2 is predicted to encode a gene product with phosphoesterase activity. Consistent
with these predictions, a DCR2 allele carrying a His338 point mutation, which in known protein phosphatases
prevents catalysis but allows substrate binding, antagonized the function of the wild-type DCR2 allele. Finally,
we report genetic interactions involving GID8, DCR2, and CLN3 (which encodes a G1 cyclin) or SWI4 (which
encodes a transcription factor of the G1/S transcription program). Our findings identify two gene products with
a probable regulatory role in the timing of initiation of cell division.
Extensive studies have identified a large number of the com-
ponents of the eukaryotic cell division machinery that bring
about cell cycle transitions once cell division is initiated. How-
ever, very little is known about the factors that determine when
the cell begins a new round of cell division. Tight coordination
between cellular “growth” and cell division is thought to de-
termine the timing of initiation of cell division, thus becoming
rate limiting for cell proliferation (23, 25). In the yeast Sac-
charomyces cerevisiae various aspects of the cell’s physiology
are monitored at a point called START in the late G1 phase of
the cell cycle (25), prior to DNA synthesis (in S phase). If cells
pass through START, they initiate DNA replication and they
are committed to complete cell division. START completion is
also followed by the appearance of a bud on the cell surface,
which will eventually give rise to the daughter cell (25).
Protein complexes of G1 cyclins (Cln1-3p) with the Cdc28p
cyclin-dependent kinase catalyze passage through START,
with the Cln3p/Cdc28p complex functioning first in activating a
large G1/S transcriptional program (29, 31). A detailed molec-
ular understanding of the factors and processes that trigger the
Cln3p/Cdc28p-mediated START completion is still lacking.
Past attempts to identify START regulatory genes have pri-
marily relied on alterations of cell size (16, 24, 30, 35) or
resistance to the antimitogenic properties of pheromone (6, 8,
26). We have recently described a different approach to iden-
tify gene products that alter the timing of START, which does
not depend on cell size changes or the response to pheromone
(1). Our method relied on the cell cycle-dependent surface
localization of Flo1p, at the tip of the growing bud, after
START completion. Cells that completed START faster than
the wild type were selected by the appearance of Flo1p on the
surface of a newly formed bud. Using this approach we iden-
tified DCR2 (YLR361C) and GID8 (DCR1/YMR135C), among
others. DCR2 has not been studied previously. In a recent
genome-wide study Gid8p was implicated in the glucose-in-
duced degradation of fructose-1,6-biphosphatase and negative
regulation of gluconeogenesis (27).
In this study we report that increased dosage of GID8 or DCR2
alters cell cycle progression, while loss of GID8 and DCR2 delays
START. We present evidence that Gid8p may function upstream
of Dcr2p to positively control the timing of START. Finally, we
report that Dcr2p may function as a phosphoesterase and that this
function may be important for START completion.
MATERIALS AND METHODS
Media, strains, and plasmids. Media were prepared as described by Kaiser et
al. (17), with the necessary biosynthetic requirements. All yeast molecular biol-
ogy techniques were performed as described by Kaiser et al. (17), unless other-
wise indicated. The strains used in this study are listed on Table 1. One-step gene
replacements utilizing the his3MX and kanMX cassettes were done as described
by Longtine et al. (19). For other gene replacements, URA3 was amplified by
PCR with specific oligonucleotide primers carrying at their 5 ends sequences
that corresponded to flanking chromosomal sequences upstream and down-
stream of the open reading frame (ORF) that was replaced. The PCR products
generated in this manner were then used directly in integrative transformations.
The genotypes of all the strains were verified by PCR as described previously
(12). The diploid strain coexpressing Gid8p-hemagglutinin (HA) and Dcr2p-Myc
(SCMSP115) was obtained from a cross of DCR2-HA (SCMSP89) and GID8-
MYC (SCMSP106) strains. The Cln3p-PrA strain (VAY27-1A) and its otherwise
isogenic untagged counterpart (VAY27-1C) were gifts from F. Cross (7). To
generate the strains shown on Fig. 8 and Table 4, we crossed a gid8 dcr2 strain
(SCMSP112) with strains lacking CLN3 (10366), BCK2 (16163), or SWI4
(16109). The resulting diploids were sporulated, and the segregants were ob-
tained by random spore analysis and tetrad dissection (17). The phenotypes
reported for each strain were obtained after examining several independent
transformants or segregants for the strain in question.
The CLN3-2D-CEN plasmid p205 (see Fig. 1) and the PGAL-CLN3 low-copy-
number plasmid pW16 (see Fig. 2) were gifts from F. Cross (5). The high-copy-
number plasmids described in this report were isolated from a yeast genomic
DNA library (4) as we previously described (1). Standard molecular biology
techniques (28) with reagents from New England Biolabs (Beverly, Mass.) were
used to characterize the plasmids isolated from our enrichment procedure (1).
The plasmid inserts were sequenced with vector-specific primers from both ends.
Sequencing was performed at the Texas A&M University Genome Technologies
Laboratory. We then digested the plasmids with the restriction endonucleases
indicated in Table 2. The products were gel purified by DNA agarose gel elec-
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trophoresis to remove the small DNA fragments released from the digestion reac-
tion. The purified products were then treated with T4 DNA polymerase to generate
blunt ends and religated to produce the plasmid derivatives indicated in Table 2.
These plasmid derivatives were then transformed into the BY4743 strain, and the
budding indices of the transformants were evaluated (see Table 2).
To construct the DCR2-H338A point mutant allele (see Fig. 6), we used two
complementary oligonucleotides that encoded the desired H338A substitution:
DCR2-H338A-FWD (5-TTCCGTGGGCAATGGTATGGGGAAATGCCGA
CGACGAGGGAAGCTTAACGCGCTGGCAG-3) and DCR2-H338A-REV
(5-TGCCAGCGCGTTAAGCTTCCCTCGTCGTCGGCATTTCCCCATACC
ATTGCCCACGGAA-3). These were then used in two separate PCRs with
plasmid 2-6 (XhoI-SmaI) as the template and primers corresponding to se-
quences flanking the DCR2 ORF downstream (5-CTGATGTCGCAGGACGA
GTC-3; used with the DCR2-H338A-FWD primer) and upstream (5-TAACT
TGTATAAAGCTGCGC-3; used with the DCR2-H338A-REV primer). The
two PCR products were then purified after agarose gel electrophoresis and used
in a third overlap extension PCR (14) with the outside flanking primers. The
product of this reaction was isolated and cotransformed into yeast cells together
with plasmid 2-6 (XhoI-SmaI), which was previously linearized by KpnI and
SacI digestion (cutting at positions 34 and 712 of the DCR2 ORF, respec-
tively). The gap-repaired plasmid derivative was then recovered from yeast
transformants by standard methods (17). The chromosomal insert spanning
DCR2 (DCR2 is on chromosome XII from position 849123 to 847387) was then
sequenced from position 849643 to 846970 to verify the introduced H338A
mutation and the absence of any other mutations. This plasmid was called
DCR2-H338A, and it was used in the experiments shown in Fig. 6 and 7.
Cell synchronization. For the elutriations shown in Fig. 1, the cells were
collected at a pump speed of 62 ml/min and rotor speed of 2,400 rpm, by using
a Beckman J6 M/E centrifugal elutriator, and cultured in synthetic complete
(SC) glucose-containing media at 30°C. For the experiments shown in Fig. 2, the
cells were grown and elutriated in SC-raffinose media at a pump speed of 33
ml/min and rotor speed of 2,400 rpm. After elutriation, galactose (at 2%, wt/vol)
was used to induce expression of the gene under GAL control at time 0, as
indicated in the figure. For the experiments shown in Fig. 4, the cells were
cultured in SC glucose-containing media and collected at a pump speed of 40
ml/min and rotor speed of 2,400 rpm.
For the arrest-and-release experiment shown in Fig. 1, the cells were cultured
in SC glucose-containing media at 30°C and incubated with nocodazole (Sigma,
St. Louis, Mo.) at 15 g/ml for 4 h. They were then resuspended in drug-free
media, and aliquots of the culture were collected for further analysis.
Budding index, DNA content, cell size, and doubling time measurements. The
percentage of budded cells (budding index) was evaluated as described previ-
ously (34). DNA content was evaluated by flow cytometry as described previously
(3). The mean cell volume of live unfixed samples was measured with a Beckman
Coulter Z2 Channelyzer. The data were analyzed with the manufacturer’s Ac-
cuComp software. The geometric mean is indicated in each case. For population
doubling (generation) time measurements we used the Channelyzer to obtain
cell numbers (N) at multiple time points (t) during the exponential growth of the
culture. From the slope of the line obtained after plotting ln N versus t, we got
the specific growth rate constant of the culture (k). The culture’s doubling time
(g) was then calculated from the formula g  ln 2/k.
Other techniques. Immunoprecipitations for HA- and Myc-tagged proteins
were performed with kits from Pierce (Rockford, Ill.), according to the manufac-
turer’s instructions. For immunoblotting, anti-HA (rabbit polyclonal) and anti-Myc
(mouse monoclonal) antibodies were obtained from Abcam (Cambridge, Mass.) and
used at a 1:5,000 dilution. The anti-Pgk1p antibody was from Molecular Probes
(Eugene, Oreg.) and used at a 1:2,000 dilution. Protein A fusion proteins were
detected with the peroxidase-antiperoxidase soluble-complex reagent from Sigma,
used at a 1:1,000 dilution. The horseradish peroxidase-conjugated secondary anti-
bodies used for immunoblotting were from Abcam, and they were used at a 1:10,000
dilution. The blots were processed with reagents from Pierce.
For fluorescence microscopy, unless otherwise indicated, we followed the
protocols of the Botstein laboratory, as described at http://genome-www.stanford
.edu/group/botlab/protocols.html/. DAPI (4,6-diamidino-2-phenylindole) was
from Molecular Probes. All the secondary antibodies used in immunofluores-
TABLE 1. Strains used in this study
Strain Relevant genotype Source
BY4741 MATa his3 leu2 met15 ura3 Res. Geneticsa
BY4742 MAT his3 leu2 met15 ura3 Res. Genetics
BY4743 BY4741/BY4742 Res. Genetics
VAY27-1C MATa ade2 trp1 leu2 his3 ura3 can1 F. Cross
VAY27-1A CLN3-PrA::HIS3 (VAY27-1C otherwise) F. Cross
SCMSP75 PGAL-GID8::his3MX/GID8
 (BY4743 otherwise) This study
SCMSP76 PGAL-DCR2::his3MX/DCR2
 (BY4743 otherwise) This study
RPY3 PGAL-DCR2::his3MX (BY4741 otherwise) This study
SCMSP112 gid8::URA3 dcr2::his3MX (BY4741 otherwise) This study
6576 gid8::kanMX (BY4741 otherwise) Res. Genetics
RPY1 dcr2::his3MX (BY4741 otherwise) This study
SCMSP89 DCR2-3HA::kanMX (BY4742 otherwise) This study
SCMSP107 DCR2-13MYC::his3MX (BY4741 otherwise) This study
SCMSP101 GID8-3HA::kanMX (BY4742 otherwise) This study
SCMSP106 GID8-13MYC::his3MX (BY4741 otherwise) This study
SCMSP115 GID8-3HA::kanMX/GID8 DCR2-13MYC::his3MX/DCR2 (BY4743 otherwise) This study
SCMSP116 gid8::URA3 (BY4741 otherwise) This study
SCMSP131 cln3::kanMX gid8::URA3 dcr2::his3MX (BY4741 otherwise) This study
SCMSP123 cln3::kanMX gid8::URA3 (BY4741 otherwise) This study
SCMSP124 swi4::kanMX gid8::URA3 (BY4741 otherwise) This study
SCMSP137 swi4::kanMX gid8::URA3 dcr2::his3MX (BY4741 otherwise) This study
SCMSP134 bck2::kanMX gid8::URA3 (BY4741 otherwise) This study
SCMSP136 bck2::kanMX gid8::URA3 dcr2::his3MX (BY4741 otherwise) This study
SCMSP127 cln3::kanMX dcr2::his3MX (BY4741 otherwise) This study
SCMSP135 bck2::kanMX dcr2::his3MX (BY4741 otherwise) This study
SCMSP128 swi4::kanMX dcr2::his3MX (BY4741 otherwise) This study
YSC1178-7501699 SIC1-TAP::his3MX (BY4741 otherwise) Open Biosystems
10366 cln3::kanMX (BY4742 otherwise) Res. Genetics
16163 bck2::kanMX (BY4742 otherwise) Res. Genetics
16109 swi4::kanMX (BY4742 otherwise) Res. Genetics
36189 bub2::kanMX/bub2::kanMX (BY4743 otherwise) Res. Genetics
31392 mad2::kanMX/mad2::kanMX (BY4743 otherwise) Res. Genetics
36781 mad3::kanMX/mad3::kanMX (BY4743 otherwise) Res. Genetics
a Res. Genetics, Research Genetics.
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cence were from Jackson ImmunoResearch (West Grove, Pa.). The samples
were examined with a Nikon Eclipse TS100 inverted fluorescence microscope.
For the phosphatase assays reported in Fig. 6, crude cell extracts were mixed
with an equal volume of assay buffer containing 200 mM Tris-HCl (pH 7.8), 2
mM MgCl2, 20 mM dithiothreitol, and 40 mM 4-nitrophenylphosphate, prepared
fresh each time. The protein concentration of the crude cell extract in the
supernatant was determined by the Bradford assay with reagents from Sigma,
according to the manufacturer’s instructions. To obtain the enzymatic rates, the
absorbance was measured at 405 nm every 5 s for 1 min with a Beckman DU 530
spectrophotometer.
RESULTS
GID8 and DCR2 alter cell cycle progression when overex-
pressed. We identified plasmids 5–18 and 2–6 in a screen for
cell cycle regulators (1). Both plasmids significantly increased
the fraction of budded cells (budding index) without altering
the overall generation time in asynchronous cultures (Tables 2
and 3). Within the chromosomal insert of plasmid 5–18 there
are the full-length ORFs of REC114, YMR134W, and
YMR135C. Plasmid 2–6 carries VPS38, YLR361C, and
YLR361C-A.
To identify the genes of interest, we disrupted individual
ORFs by digestion with restriction endonucleases and religa-
tion and, in transformants carrying these plasmid derivatives,
we looked for budding index values similar to that for the wild
type. Removing a BamHI-BglII fragment from plasmid 5–18,
which disrupts only YMR135C (Table 2), led to the loss of the
high-budding-index phenotype of the cells carrying this plas-
mid derivative, implying that YMR135C was the gene of inter-
est on plasmid 5–18. Likewise, digestion of plasmid 2–6 with
BglII disrupted VPS38 and YLR361C, while digestion with
KpnI and SalI disrupted YLR361C-A and YLR361C. In both
cases the plasmid derivatives did not increase the budding
index (Table 2), and, since the YLR361C ORF was the com-
FIG. 1. Gid8p and Dcr2p affect cell cycle progression. (A) Synchronous cultures of BY4743 cells carrying the empty vector-2, GID8-2, or
DCR2-2 were obtained by elutriation. At the indicated time points the DNA content was evaluated by flow cytometry. Cell numbers are plotted
on the y axis, and the x axis indicates fluorescence intensity. Cell cycle progression was also monitored by determining the percentage of unbudded
cells (%UB). Cell size was measured with a Channelyzer. (B) Cells carrying the indicated plasmids and a TAP-tagged copy of SIC1 were arrested
with nocodazole for 4 h and then released into drug-free fresh SC-glucose-containing media at 30°C. Aliquots of the culture at the indicated times
were then processed for immunoblotting against Sic1p fused to the tandem affinity purification (TAP) epitope, as described in Materials and
Methods. The blots were also stained with Ponceau S to indicate protein loading. (C) The cell sizes for asynchronous cultures of diploid BY4743
cells in SC-glucose media at 30°C carrying the indicated plasmids are shown. For these samples, the geometric means and standard deviations for
vector-2, GID8-2, and DCR2-2 transformants were 76  2, 74  2, and 78  2, respectively. (D) Sensitivity to -factor of haploid BY4741
cells carrying the indicated plasmids was evaluated by spotting 10-fold serial dilutions of the corresponding cultures on solid media containing
increasing concentrations of -factor. The plates were incubated at 30°C and photographed after 2 days.
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mon ORF disrupted in these two cases, we concluded that it
might be the gene of interest. We reserved the names DCR1
and DCR2 (dosage-dependent cell cycle regulators 1 and 2) for
YMR135C and YLR361C, respectively, with the Saccharomyces
Genome Database, according to their guidelines (http://www
.yeastgenome.org/gene_guidelines.shtml). In the meantime,
another group implicated YMR135C in proteasome-mediated
degradation of fructose-1,6-biphosphatase and down regula-
tion of gluconeogenesis and named it GID8 (27). Hereafter, we
refer to plasmids 5–18 and 2–6 as GID8-2 and DCR2-2,
respectively. Based on reverse transcription-PCR experiments,
cells carrying the high-copy-number plasmids overexpress
GID8 about 10-fold and overexpress DCR2 about 2-fold (data
not shown).
Next we examined the effect of GID8 and DCR2 overexpres-
sion on cell cycle progression in a synchronous population of
cells obtained by elutriation (Fig. 1). Cells carrying GID8-2
and DCR2-2 had a shorter G1 based on budding index and
DNA content measurements (Fig. 1A). For example, 45 min
after elutriation 79% of wild-type cells were unbudded, com-
pared to only 32% of cells overexpressing GID8 or DCR2 (Fig.
1A). GID8- and DCR2-overexpressing cells also appear to ini-
tiate DNA replication at a smaller size than wild-type cells
(Fig. 1A; at 30 or 45 min after elutriation). These results
suggest that synchronous cultures of cells containing GID8-2
and DCR2-2 complete START faster than wild-type cells,
consistent with results obtained from asynchronous popula-
tions of cells where overexpression of these genes increased
the budding index (Table 2 and results below).
We also monitored the levels of the Cdk inhibitor Sic1p in
cultures released from a nocodazole arrest (Fig. 1B). In cells
carrying GID8 or DCR2 on a high-copy-number plasmid, Sic1p
disappeared sooner (15 min), indicative of a shortened G1
phase (Fig. 1B). Finally, asynchronous populations of GID8-
and DCR2-overexpressing cells were neither smaller overall
nor pheromone resistant (Fig. 1C and D), in contrast to CLN3-
overexpressing cells, which are smaller and resistant to pher-
omone (6, 22).
Gid8p and Dcr2p affect cell cycle progression by regulating
START. GID8 and DCR2 overexpression may alter cell cycle
progression either by directly shortening the G1 phase, which
leads to a high budding index due to a compensatory expansion
of subsequent cell cycle phases, or by simply delaying mitotic
progression (34). A mitotic delay can lead to a shorter G1
phase in the next cell cycle, presumably because it allows the
cells to grow and reach the critical size for initiation in the next
division faster. This is usually accompanied by an increase in
the doubling time and cell size of the culture (20), as we have
recently shown for SIK1 overexpression (1), which we identi-
fied in the same screen that yielded GID8 and DCR2. How-
ever, GID8- and DCR2-overexpressing cells were not larger
than wild-type cells (Fig. 1A and C), and they proliferated at
the same rate as wild-type cells (94 3, 91 1, and 95 3 min
for vector-2, GID8-2, and DCR2-2 transformants, respec-
tively, at 30°C in SC-glucose media).
We then used heterozygous diploid cells where one copy of
GID8 or DCR2 was under the control of a galactose-inducible
promoter while the other was under the control of its native
promoter. The cells were grown in raffinose-containing media
before elutriation so that gene overexpression was not induced.
Postelutriation, the cells were shifted to galactose-containing
media to induce the GAL promoter and overexpress the gene
of interest. Budding index as well as flow cytometry data indi-
cated that, in the presence of galactose, the transition from the
G1 to S phase was accelerated in PGAL-GID8 and PGAL-DCR2
strains (Fig. 2). The results obtained were similar to those
when CLN3 was overexpressed in the same way, in cells car-
rying a low-copy-number PGAL-CLN3 plasmid (Fig. 2). Thus,
we conclude that Gid8p and Dcr2p most likely affect cell cycle
progression by regulating the completion of START.
If GID8 or DCR2 overexpression somehow adversely affects
progression through mitosis, this might become apparent in
cells lacking checkpoint genes (1). In that case, checkpoint
mutant cells may not be able to properly delay cell cycle pro-
gression when GID8 or DCR2 is overexpressed, with poten-
FIG. 2. Overexpression of GID8 and DCR2 accelerates completion of
START. (A) Wild-type diploid cells (WT), heterozygous for PGAL-
GID8/GID8 (GAL-GID8) or PGAL-DCR2
/DCR2 (GAL-DCR2) or
carrying a PGAL-CLN3-CEN plasmid (GAL-CLN3), were grown and elu-
triated in raffinose-containing media to obtain a synchronous early G1
population of cells in each case. Galactose was then added, and progres-
sion through the cell cycle was evaluated as for Fig. 1. All the strains were
in the BY4743 background. (B) The percentages of cells in G1 from the
flow cytometry panels in panel A were calculated from the DNA histo-
grams with the ModFit software (Verity Software House, Topsham,
Maine).
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tially catastrophic consequences. Bub2p and Mad2,3p are in-
volved in mitotic spindle checkpoint activation by two
independent partially redundant pathways, in response to mis-
takes in spindle alignment (10, 18). However, GID8 or DCR2
overexpression did not alter the viability of bub2, mad2, or
mad3 mutants (Fig. 3).
Although deletion of GID8 and DCR2, separately or in com-
bination, had no effect on the budding index or the doubling
time of the cells (Tables 3 and 4), we also examined cell cycle
progression of the resulting loss-of-function mutants in syn-
chronous cultures obtained by elutriation (Fig. 4). Combined
loss of GID8 and DCR2 led to a small but significant delay
(15 min) in the timing of initiation of DNA replication.
These cells were also 10 to 15% larger than wild-type cells
(Table 4). Loss of DCR2 did not significantly delay START,
but cells lacking GID8 were delayed almost to the same extent
as double gid8 dcr2 cells.
Overall, all our data thus far suggest that GID8 and DCR2
have a positive role in G1 and the timing of START.
Gid8p and Dcr2p functionally interact to regulate the G1/S
transition. We next examined if the GID8 and DCR2 gene
products may function in a common pathway to regulate the
completion of START. We overexpressed one gene product in
the absence of the other to see if it resulted in the loss of the
high-budding-index phenotype associated with the overexpres-
sion of the former gene product. Note that overexpression of
Gid8p does not affect Dcr2p levels and vice versa (see Fig. 7).
Interestingly, overexpression of GID8 did not increase the bud-
ding index of dcr2 cells (Table 3), indicating that Gid8p
requires the function of Dcr2p to accelerate the G1/S transi-
TABLE 2. Schematic representation of plasmids and their derivativesa
Plasmid Chromosomal inserta Relative Blb
YEp24 None 1.0  0.08
5-18 1.20  0.07
5-18 (BamHI-Bg/II) 0.98  0.07
5-18 (Xho I-Nhe I) 0.93  0.09
2-6 1.18  0.15
2-6 (BglII) 0.97  0.15
2-6 (Xho I-Sma I) 1.17  0.12
2-6 (Kpn I-Sal I) 0.94  0.10
a Genomic fragment present in each plasmid. The ORF within each insert is drawn to scale, but the scale is not the same between different inserts. Translation from
the “Watson” (or “Crick”) strand is indicated by the placement of the ORF above (or below) the line that denotes the chromosomal insert. The number of the
chromosome from which the insert is derived is indicated. The numbers on either sides of the full insert denote their respective chromosomal positions.
b The relative budding index (BI) associated with each plasmid with respect to that for the empty vector. All the measurements were performed in SC-glucose media
at 30°C. The average and standard deviation from at least 18 different transformants (all in the BY4743 background) in each case are shown.
TABLE 3. Genetic interactions between GID8 and DCR2
Straina Budding index (n; P)b
GID8 DCR2 (vector-2) ....................... 1  0.12 (19; 1)
GID8 DCR2 (GID8-2) ........................ 1.29  0.10 (18; 3 	 10
10)
GID8 DCR2 (DCR2-2) ....................... 1.14  0.12 (20; 5 	 10
4)
GID8 dcr2 (GID8-2) ........................... 1.05  0.09 (18; 0.1)
gid8 DCR2 (DCR2-2) .......................... 1.11  0.07 (19; 1 	 10
3)
gid8 DCR2 (vector-2) .......................... 1.03  0.12 (20; 0.5)
GID8 dcr2 (vector-2)........................... 1.02  0.08 (19; 0.5)
gid8 dcr2 (vector-2) ............................. 1.01  0.1 (32; 0.8)
GID8 DCR2 (vector-2)* ..................... 1  0.05 (30)
GID8 DCR2 (GID8-2)* ...................... 1.17  0.05 (30; 7 	 10
11)
GID8 PGAL-DCR2 (vector-2)*.............. 1.23  0.10 (30; 8 	 10

9)
GID8 PGAL-DCR2 (GID8-2)*............... 1.22  0.08 (30; 3 	 10

10)
a The cells (all in the BY4741 background) were grown in SC media, at 30°C,
with glucose or galactose (*) as the carbon source. In these growth conditions,
the generation times of all strains were indistinguishable from those of the wild
type (94  3 min in glucose-containing media and 165  5 min in galactose-
containing media).
b The mean and standard deviation of the relative budding index, compared to
those for the wild type, are shown in each case. The numbers of individual
cultures evaluated (n) and the probabilities associated with Student’s t test when
the budding indices are compared to that for the wild type are shown in paren-
theses.
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tion. In contrast, Dcr2p does not depend on Gid8p to regulate
START, since gid8 cells containing the DCR2-2 plasmid still
had a higher budding index than wild-type cells (Table 3).
Simultaneous overexpression of both genes, by introducing the
GID8-2 plasmid in PGAL-DCR2 cells and then growing the
cells in the presence of galactose, did not produce an additive
effect (Table 3). Similar results (see Fig. 6) were also observed
when GID8 was galactose induced and DCR2 was on a high-
copy-number plasmid. The simplest interpretation of our data
is that, to some extent, Gid8p may function in the same path-
way with and upstream of Dcr2p to accelerate the G1/S tran-
sition. This conclusion is further supported by additional ex-
periments that we describe below, based again on budding
index measurements (see Fig. 6). However, from the cell cycle
profiles (Fig. 4) and additional experiments we describe below
(see Fig. 8), combined loss of Gid8p and Dcr2p had the stron-
gest phenotypic consequences, arguing against an exclusive
linear pathway for these two gene products.
Subcellular localization of Dcr2p. Localization data for
Gid8p are available from a genome-wide database (15) (Gid8p
was present in both the nucleus and the cytoplasm), but there
is no record for Dcr2p’s subcellular localization in any data-
base. Consequently, we epitope tagged Gid8p and Dcr2p with
HA and c-Myc epitope tags (19). In both cases proteins of the
expected size were detected from cell extracts after immuno-
precipitations and immunoblotting with anti-HA and anti-Myc
antibodies (Fig. 5). Cells carrying the epitope-tagged proteins
were indistinguishable from the wild type, based on generation
time, cell size, and budding index measurements (data not
shown). Overexpression of GID8 in strains carrying a epitope-
tagged DCR2 allele still increased the budding index (data not
shown). Since Gid8p requires the presence of functional Dcr2p
(Table 3), the epitope-tagged Dcr2p probably retains function.
Based on the granular staining pattern by immunofluorescence
of the HA- or Myc-tagged Gid8p or Dcr2p, we conclude that
Gid8p and Dcr2p are present in distinct foci throughout the
cell (Fig. 5). Similar results were obtained with a strain carrying
a green fluorescent protein-tagged DCR2 allele (data not
shown). Despite the similar staining patterns obtained in cells
carrying either Gid8p or Dcr2p fusion proteins, in cells coex-
pressing both there was no evidence of colocalization (Fig.
5C). Attempts to coimmunoprecipitate Gid8p and Dcr2p from
these cells were also unsuccessful (data not shown).
DCR2-H338A antagonizes wild-type DCR2. The DCR2 ORF
is predicted to encode a 578-amino-acid protein of 66,463 Da.
Motif searches suggested that Dcr2p may belong to a family of
calcineurin-like metal-containing phosphoesterases (E value 
1e
5, from CDART [11]), which includes protein phospho-
serine phosphatases, nucleotidases, nucleases, sphingomyelin
FIG. 3. Overexpression of GID8 (A) or DCR2 (B) does not affect
the viability of cells lacking mitotic checkpoint genes. Growth of
bub2/bub2, mad2/mad2, and mad3/mad3 strains (all in the
BY4743 background) carrying the indicated plasmids was evaluated by
spotting 10-fold serial dilutions of the cultures on solid media. The
plates were incubated at 30°C and photographed after 2 days.
TABLE 4. Proliferation parameters of CLN3, BCK2, SWI4, GID8,
and DCR2 mutantsa
Strain gb Cell size(m3)
WTc 1  0.02 36.6  1.6
gid8 1.01  0.01 37.1  1.6
dcr2 1.01  0.02 37.0  1.6
gid8 dcr2 1  0.03 42.0  1.6
bck2 1  0.02 45.6  1.7
bck2 gid8 dcr2 1  0.02 49.5  1.7
cln3 1.05  0.03 49.2  1.7
cln3 gid8 dcr2 1.05  0.02 54.3  1.8
swi4 1.08  0.01 48.4  1.7
swi4 gid8 dcr2 1.07  0.01 56.8  1.9
a Cell numbers and cell sizes were obtained with a Coulter counter as de-
scribed in Materials and Methods. The average and standard deviation from
three independent liquid cultures in rich yeast extract-peptone-dextrose media
are shown in each case. All the strains were in the haploid BY4741 background.
b The generation times (g) of the strains shown are relative to that of wild type,
which was 94  1.9 min.
c WT, wild type.
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phosphodiesterases, and 2-3 cyclic AMP phosphodiesterases.
Within the conserved  phosphoesterase structure there are
sequence “signatures” common to these proteins. Among them is
a GNHD/E sequence motif, thought to be important for the
hydrolysis of phosphate esters in the active-site dinuclear metal
center (36). Mutational analysis suggested that the His of the
GNHD motif probably affects catalysis but not substrate binding
in  Ser/Thr phosphatase and calcineurin (21, 36).
To test the possibility that Dcr2p may function as a phos-
phoesterase, we introduced an H338A mutation in the GNHD
motif of Dcr2p (Fig. 6A). The presence of this DCR2-H338A
allele does not alter the endogenous levels of Dcr2p or Gid8p
(Fig. 7). In phosphatase assays with 4-nitrophenylphosphate as
a substrate, crude extracts from cells lacking DCR2 or carrying
the DCR2-H338A allele had significantly lower (20%) phos-
phatase activity than extracts from wild-type cells (Fig. 6B).
However, in the same assays extracts from cells overexpressing
DCR2 had only minimally increased (5%) phosphatase ac-
tivity (Fig. 6B). This could be due to the high background of
this crude assay.
FIG. 4. Loss of GID8 and DCR2 delays completion of START. (A) Wild-type (WT) haploid cells and gid8, dcr2, and gid8 dcr2 cells were
grown and elutriated in SC-glucose-containing media. All the strains were in the BY4741 background. At the indicated time points the DNA
content was evaluated by flow cytometry. Cell numbers are plotted on the y axis, and the x axis indicates fluorescence. Cell size was measured with
a Channelyzer. The percentage of G1 cells was calculated from the DNA histograms with ModFit software (Verity Software House). (B) Cell cycle
progression was also monitored by determining the percentage of budded cells, from the samples shown in panel A.
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We then examined the ability of the DCR2-H338A allele to
interfere with the two phenotypic attributes of the wild-type
DCR2: first, overexpression of DCR2 increases the budding
index; second, DCR2 is necessary for GID8 overexpression
to increase the budding index. However, in cells carrying
DCR2-H338A, overexpression of wild-type DCR2 (Fig. 6B)
or GID8 (Fig. 6C) did not increase the budding index.
Therefore, DCR2-H338A is an antimorph or dominant neg-
ative, presumably because it encodes a mutant protein ca-
pable of antagonizing the wild-type DCR2 gene product.
These results are consistent with a putative role for Dcr2p as
a phosphoesterase.
Functional interactions with other START regulators. Cells
carrying GID8 or DCR2 high-copy-number plasmids do not
have altered Cln3p levels (Fig. 8A), consistent with the fact
that, for these cells, size and resistance to pheromone are
similar to those for wild-type cells (Fig. 1). We then overex-
pressed GID8 and DCR2 in cells lacking CLN3. Interestingly,
in the absence of CLN3 GID8-2 and DCR2-2 did not in-
crease the budding index, suggesting that Gid8p and Dcr2p
may regulate cell cycle progression via Cln3p (Fig. 8B). Thus,
a role for Gid8p and Dcr2p in G1 might require Cln3p, but it
does not lead to higher Cln3p levels.
We then deleted GID8 and/or DCR2 in cells lacking CLN3,
BCK2, or SWI4. Bck2p activates START in a Cln3p-indepen-
dent manner (33), while Swi4p is a G1/S transcription factor
(2). Cells lacking CLN3, BCK2, or SWI4 proliferate at almost
the same rate as wild-type cells in rich media, but these mu-
tants are larger than wild-type cells (Table 4). Interestingly,
mutants with deletions of CLN3, BCK2, or SWI4 as well as
GID8 and DCR2 were even larger (Table 4). The growth rate
of the triple mutants was similar to those of cells with a single
CLN3, BCK2, or SWI4 deletion in rich liquid (Table 4) or solid
(Fig. 8C) media. Surprisingly, in the presence of high salt
concentrations there were clear effects, with the triple cln3
gid8 dcr2 and swi4 gid8 dcr2 mutants growing very
poorly (Fig. 8C). Cells with double mutations in GID8 or
DCR2 and CLN3 or SWI4 proliferated normally, suggesting
that GID8 and DCR2 might have synergistic functions under
these conditions. Slightly poorer growth was also evident in
bck2 gid8 dcr2 cells, but the effect was not as pronounced
(Fig. 8C). Therefore, Gid8p and Dcr2p are required for normal
rates of cell proliferation under high salt concentrations and in
the absence of Cln3p or Swi4p.
DISCUSSION
In this study we have shown that Gid8p and Dcr2p affect cell
cycle progression by regulating the completion of START. We
discuss these findings in the general context of START control.
FIG. 5. Subcellular localization of Gid8p and Dcr2p. (A and B, top) Immunoblots showing HA- or Myc-tagged Gid8p and Dcr2p, immuno-
precipitated from cell extracts of the corresponding strains. (Bottom) Cells carrying a single epitope-tagged copy of the product of GID8 or DCR2,
expressed from its native chromosomal location, or untagged controls (BY4742 for the HA-tagged strains or BY4741 for the Myc-tagged strains)
were photographed through phase optics (left) and by fluorescence microscopy. The nuclei (middle) were visualized by DAPI staining. Epitope-
tagged Gid8p or Dcr2p (right) were visualized by immunofluorescence. (C) Cells coexpressing Gid8p-HA and Dcr2p-Myc were processed as
described for panels A and B and compared to the untagged control strain (BY4743). The merged colored image was produced by false coloring
the Gid8p-HA image green and the Dcr2p-Myc image red.
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Why have GID8 and DCR2 not been previously identified in
various screens for START regulators? Since GID8 and DCR2
are not essential, they were not targeted by the classic cdc
mutant screen done by Hartwell and colleagues, which focused
on essential genes (13). Cells overexpressing GID8 and DCR2
seem to initiate START at a smaller size than wild-type cells
(Fig. 1A and 2A), similar to CLN3-overexpressing cells (Fig.
2A). However, unlike overexpression of CLN3, overexpression
of GID8 or DCR2 does not change the overall size of the
population (Fig. 1C), probably because these cells continue
FIG. 6. Dcr2p might function as a phosphoesterase. (A) DCR2 is predicted to encode a polypeptide with a metallophosphoesterase (metallophos)
domain. Numbers indicate amino acid positions of the predicted Dcr2p polypeptide. (B) Relative phosphatase specific activity from crude cell extracts
(means standard deviations; n 3) from haploid cells. Where indicated, the strains were transformed with a high-copy-number plasmid carrying DCR2
(DCR2-2, DCR2-H338A (DCR2-H338A-2), or the empty high-copy-number vector (vector-2). (C) Relative budding indices (BI) of DCR2 and
PGAL-DCR2
 cells (in the BY4741 background) carrying the indicated plasmids. The averages and standard deviations from at least eight independent
transformants in each case are indicated. (D) Relative budding indices of GID8/GID8 and PGAL-GID8
/GID8 cells (in the BY4743 background)
carrying the indicated plasmids. The averages and standard deviations from at least eight independent transformants in each case are indicated.
VOL. 3, 2004 Gid8p AND Dcr2p PROMOTE START 1635
 o
n
 Septem
ber 21, 2018 by guest
http://ec.asm
.org/
D
ow
nloaded from
 
growing to the same size as wild-type cells in subsequent
phases of the cell cycle after START completion. They also
retain sensitivity to the antimitogenic properties of pheromone
(Fig. 1D). Consequently, they would have been missed by pre-
vious approaches that relied on overall changes in cell size or
resistance to pheromone for the identification of START reg-
ulators (6, 8, 16, 24, 26, 30, 35). These properties of GID8 and
DCR2 mutants are important because they suggest that the list
of START regulators may be larger than previously thought.
At this point, we can only speculate about the possible
role(s) of GID8 and DCR2 in START control. Neither GID8
nor DCR2 mRNA levels are cell cycle regulated (29). Gid8p is
predicted to contain LisH and CTLH domains (27). These
domains have been previously associated with cytoskeletal
functions (9). Recently, the mammalian cyclin E/Cdk2 sub-
strate p220 (NPAT) was shown to regulate G1/S histone tran-
scription through its LisH domain (32). It is important, how-
ever, that no clear function can be deduced from the presence
FIG. 7. Steady state levels of Myc-tagged Gid8p and Dcr2p in cells
carrying the indicated high-copy-number plasmids or the untagged
control strain are shown on an immunoblot produced with an anti-Myc
antibody. The corresponding levels of Pgk1p are shown as a loading
control. All the cells were in the haploid BY4741 background.
FIG. 8. Functional interactions with other START regulators. (A) The steady-state levels of Cln3p-PrA are shown on an immunoblot, from
cells carrying the indicated plasmids (in the VAY27-1A background) and the untagged control strain (VAY27-1C). The corresponding levels of
Pgk1p are shown as a loading control. (B) Relative budding indices (BI) of CLN3/CLN3 and cln3/cln3 cells (in the BY4743) background)
carrying the indicated plasmids. The averages and standard deviations from at least eight independent transformants in each case are shown. The
probability associated with a Student’s t test when the indicated samples were compared is shown. (C) Growth of the indicated strains was evaluated
by spotting 10-fold serial dilutions of the cultures on solid rich media (yeast extract-peptone-dextrose [YPD]). The plates were incubated at 30°C
and photographed after 2 (YPD) or 4 to 5 (YPD plus 1.2 M NaCl) days.
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of these domains. Gid8p does not appear to colocalize with the
cytoskeleton based on genome-wide localization data (15) and
our own observations (Fig. 5). It was also recently suggested
that Gid8p is involved in proteasome-mediated catabolite deg-
radation of fructose-1,6-biphosphatase when cells are trans-
ferred from a nonfermentable carbon source to glucose (27).
However, since all our experiments did not involve such media
changes and since the GID8 overexpression phenotype was
evident in steady-state conditions in glucose-rich media, it is
unclear what role (if any) this activity might play in the regu-
lation of START.
Based on genetic evidence, Gid8p and Dcr2p may function
through a common pathway, with Dcr2p being downstream of
Gid8p (Table 3 and Fig. 6), to positively control the timing of
START. It is also clear that Gid8p’s effects on overall cell
proliferation may not solely depend on the presence of Dcr2p,
because their combined loss produces more-severe cell size
(Table 4) and viability phenotypes in the context of other cell
cycle mutations (Fig. 8). The cell size enlargement when GID8
and DCR2 were both deleted was additive to that due to CLN3,
BCK2, or SWI4 deletions (Table 4). Combined loss of GID8,
DCR2, and SWI4 or CLN3 severely affects overall cell prolif-
eration in high-salt conditions (Fig. 8C). The increase in the
budding index of cells carrying GID8 or DCR2 high-copy-
number plasmids appears to require the presence of CLN3
(Fig. 8B). Nonetheless, the synthetic effects observed in the
plate growth assays on high salt suggest that Gid8p and Dcr2p
may also have synergistic functions with Cln3p and Swi4p un-
der these conditions.
The “output” of the Gid8p/Dcr2p pathway will likely involve
some type of phospho-ester hydrolysis, since our data strongly
point to a phosphoesterase activity of Dcr2p (Fig. 6). This
activity could be directed to any one of several types of sub-
strates (for example lipids, nucleic acids, and proteins). It will
be an important goal of future studies to identify the sub-
strate(s) of Dcr2p as well as any other factor(s) that impinges
on Gid8p/Dcr2p and that is physiologically relevant for cell
cycle progression. Overall, our data point to an important role
for Gid8p and Dcr2p in the timing of START, and a better
understanding of their function(s) at the molecular level will
contribute to our understanding of the G1/S transition.
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